A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE)

BACKGROUND: Disease recurrence is the main cause of mortality after resection of pancreatic ductal adenocarcinoma (PDAC). In 20–30% of resected patients, isolated local PDAC recurrence occurs. Retrospective studies have suggested that stereotactic body radiation therapy (SBRT) might lead to improved...

Descripción completa

Detalles Bibliográficos
Autores principales: van Goor, I. W. J. M., Daamen, L. A., Besselink, M. G., Bruynzeel, A. M. E., Busch, O. R., Cirkel, G. A., Groot Koerkamp, B., Haj Mohammed, N., Heerkens, H. D., van Laarhoven, H. W. M., Meijer, G. J., Nuyttens, J., van Santvoort, H. C., van Tienhoven, G., Verkooijen, H. M., Wilmink, J. W., Molenaar, I. Q., Intven, M. P. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617359/
https://www.ncbi.nlm.nih.gov/pubmed/36307892
http://dx.doi.org/10.1186/s13063-022-06829-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617359/
https://www.ncbi.nlm.nih.gov/pubmed/36307892
http://dx.doi.org/10.1186/s13063-022-06829-1

Ejemplares similares